BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Contract Research

Avance Clinical Appoints Jessica Han as Director of Asian Operations, Strengthening Commitment to the Asian Market

Avance Clinical, the award-winning CRO for biotechs, is proud to announce the appointment of Jessica Han as Director, Asian Operations based out of the Ava...

July 22, 2024 | News

GCCL Launches R&D Division to Bolster Biosimilar and Clinical Trial Analysis Services

Newly established R&D division this year is expected to provide full-scale in-house R&D in addition to clinical sample analysis Including blockb...

July 17, 2024 | News

Thermo Fisher Scientific Expands Kentucky Operations with $47.8 Million Investment

The PPD clinical research business of Thermo Fisher Scientific Inc., the world leader in serving science, today announced the expansion of its central labo...

June 28, 2024 | News

Porton Advanced Integrates MaxCyte cGMP-Grade Electroporation System into Cell Therapy Platform

Porton Advanced recently introduced the MaxCyte cGMP-grade ExPERT GTx Flow Electroporation instrument to its cell therapy platform, marking the company as ...

June 26, 2024 | News

Syngene Launches Advanced Protein Production Platform Leveraging ExcellGene Technology

Syngene International , a leading global contract research, development and manufacturing organization (CRDMO), announces the launch of its new protein pro...

June 05, 2024 | News

Fortrea Launches Comprehensive Solution to Enhance Diversity and Inclusion in Clinical Trials

Fortrea, a leading global contract research organization (CRO), today announced its comprehensive and integrated solution to improve the diversity an...

May 31, 2024 | News

ProBioGen and ModeX Therapeutics Partner to Accelerate Development of Multi-Specific COVID-19 Antibody

ProBioGen, a leading contract development and manufacturing organization (CDMO), known for its innovative solutions in cell engineering and bioproces...

May 30, 2024 | News

WuXi AppTec Breaks Ground on New R&D and Manufacturing Site in Singapore

WuXi AppTec, a global company that provides a broad portfolio of R&D and manufacturing services to enable companies in the pharmaceutical and life scie...

May 24, 2024 | News

Allucent Secures $25.5 Million Award for Decentralized COVID-19 Trial

Allucent, a global mid-sized clinical research organization (CRO), announced that it received a project award valued at $25.5 million...

May 16, 2024 | News

AGC Biologics Completes Production of VAR2 Pharmaceuticals' Cancer-Targeting Antibodies

AGC Biologics announced the completion of work with VAR2 Pharmaceuticals on the production of the company’s two antibody candidates targeti...

April 25, 2024 | News

WuXi AppTec's Changzhou Facility Gains PMDA Approval, Bolstering Global Expansion Plans

Latest regulatory approval follows on the back of expansion plans announced during DCAT 2024 With peptides, oligos and peptide conjugates continui...

April 22, 2024 | News

Invenra and Catalent Forge Partnership to Advance Cancer Treatment Innovations

Invenra Inc., an innovative leader in bispecific antibody technology, is pleased to announce a strategic collaboration with Catalent, a global Contract Dev...

April 03, 2024 | News

Resonance Health Joins Forces with Micron, Inc. for Strategic Entry into Japan's Healthcare Sector

Resonance Health Ltd, listed on the Australian Securities Exchange (ASX) under the ticker RHT, has officially announced its strategic move into the Japanes...

March 28, 2024 | News

Aragen Biologics Launches First Phase of New Facility in India, Spearheading Novel Anticancer mAb Manufacturing

Aragen, a leading Contract Research Development and Manufacturing Organization (CRDMO) for small molecules and biologics, announced that it has operat...

March 28, 2024 | News

Stay Connected